Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

OBJECTIVES: In Canada, incidences of herpes zoster (HZ) and postherpetic neuralgia (PHN) are increasing, posing a significant burden on the healthcare system. This study aimed to determine the public health impact and cost effectiveness of an adjuvanted recombinant zoster vaccine (RZV) compared to n...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Appl Health Econ Health Policy
Päätekijät: McGirr, Ashleigh, Van Oorschot, Desiree, Widenmaier, Robyn, Stokes, Michael, Ganz, Michael L., Jung, Hyosung, Varghese, Lijoy, Curran, Desmond
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2019
Aiheet:
Original Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748891/
https://ncbi.nlm.nih.gov/pubmed/31250218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-019-00491-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia